ANVS - Annovis Bio to post late-stage data for Parkinson's drug in June
2024-05-09 15:34:49 ET
Annovis Bio ( NYSE: ANVS ) shares traded higher Thursday after the biotech said that initial data from a Phase 3 trial for its lead candidate buntanetap in early Parkinson’s disease is now expected in June....
Annovis Bio to post late-stage data for Parkinson's drug in June